Global Graves Disease Treatment Market, By Mechanism of Action (Anti-thyroid Agents, Beta Blockers, Corticosteroids and Others), Drugs (Propylthiouracil, Methimazole, Propranolol, Prednisone and Others), Diagnosis (Physical Exam, Blood Test, Radioactive Iodine Uptake Test, Ultrasound and Imaging Tests), Treatment (Medication, Radioactive Iodine Therapy, Surgery and Others), Route of Administration (Oral, Intravenous and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Global Graves Disease Treatment Market
The graves disease treatment market is expected to witness market growth at a rate of 4.50% in the forecast period of 2021 to 2028. Data Bridge Market Research report on graves disease treatment market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the iodine disorder and thyroid tumors screening is escalating the growth of graves disease treatment market.
Graves’ disease can be referred to as an autoimmune disorder of the thyroid gland that triggers the hyperthyroidism, overproduction of the thyroid hormones. The immune system attacks the thyroid gland and triggers the swelling which results in overactive thyroid and extreme production of thyroid hormones.
Major factors that expected to boost the growth of the graves disease treatment market in the forecast period are the rise in the incidence of autoimmune diseases like Grave’s disease and Hashimoto's thyroiditis. Furthermore, the several national health programs regarding the thyroid disease that raise awareness regarding such diseases is further anticipated to propel the growth of the graves disease treatment market. On the other hand, the rise in the price of related to the treatment and the utilization of the substitute medicines for the treatment of thyroid disorders is further estimated to cushion the growth of the graves disease treatment market.
In addition, the suitable reimbursement policies for the treatment will further provide potential opportunities for the growth of the graves disease treatment market in the coming years. However, strict government regulations might further challenge the growth of the graves disease treatment market in the near future.
The graves disease treatment market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the graves disease treatment market scenario contact Data bridge market research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Graves Disease Treatment Market Scope and Market Size
Regenerative medicine market is segmented on the basis of mechanism of action, drugs, treatment, route of administration, distribution channel and end users. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of mechanism of action, the graves disease treatment market is segmented into anti-thyroid agents, beta blockers, corticosteroids and others.
- On the basis of drugs, the graves disease treatment market is segmented into propylthiouracil, methimazole, propranolol, prednisone and others.
- On the basis of treatment, the graves disease treatment market is segmented into medication, radioactive iodine therapy, surgery and others.
- On the basis of route of administration, the graves disease treatment market is segmented into oral, intravenous and others
- On the basis of distribution channel, the graves disease treatment market is segmented into hospital pharmacy, retail pharmacy, online pharmacy
- On the basis of end users, the graves disease treatment market is segmented into hospitals, homecare, specialty clinics, others.
Graves Disease Treatment Market Country Level Analysis
The graves disease treatment market is analysed and market size information is provided by country, mechanism of action, drugs, treatment, route of administration, distribution channel and end users as referenced above.
The countries covered in the graves disease treatment market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).
North America dominates the graves disease treatment market due to the rise in the thyroid related disorders. Furthermore, the increase in the in awareness about hyperthyroidism will further boost the growth of the graves disease treatment market in the region during the forecast period. Asia-Pacific is projected to observe significant amount of growth in the graves disease treatment market due to the thyroid related disorders drugs because of the increase in the health care investments. Moreover, the increase in the consciousness about hyperthyroidism is further anticipated to propel the growth of the graves disease treatment market in the region in the coming years.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Regenerative medicine market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Graves Disease Treatment Market Share Analysis
The graves disease treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to graves disease treatment market.
The major players covered in the graves disease treatment market report are Abbott, GlaxoSmithKline plc, ALLERGAN, Novartis AG, Merck & Co., Inc, Sanofi, Pfizer Inc, AbbVie Inc, Mylan N.V, Apitope, Merck KGaA, Amgen Inc, , Horizon Therapeutics plc, Medtronic, Immunovant, Inc, Sun Pharmaceutical Industries Ltd., GlaxoSmithKline Plc., Lupin Pharmaceuticals Inc., Bayer AG, Lupin Pharmaceuticals Inc., among other domestic and global players. The graves disease treatment market share data is available for global, North America, South America, Europe, Asia-Pacific (APAC) and Middle East and Africa (MEA) separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-